stocks logo

ENVB Valuation

Enveric Biosciences Inc
$
1.130
-0.13(-10.317%)1D
  • Overview
  • Forecast
  • Valuation
  • Earnings

ENVB Relative Valuation

ENVB's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ENVB is overvalued; if below, it's undervalued.
Intellectia AI SwingMax

Historical Valuation

Enveric Biosciences Inc (ENVB) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -1.48. The fair price of Enveric Biosciences Inc (ENVB) is between to according to relative valuation methord.
Relative Value
Fair Zone
-
Current Price:1.26
Fair
-1.31
PE
1Y
3Y
5Y
Trailing
Forward
-0.22
EV/EBITDA
Enveric Biosciences Inc. (ENVB) has a current EV/EBITDA of -0.22. The 5-year average EV/EBITDA is 0.07. The thresholds are as follows: Strongly Undervalued below -0.44, Undervalued between -0.44 and -0.19, Fairly Valued between 0.32 and -0.19, Overvalued between 0.32 and 0.57, and Strongly Overvalued above 0.57. The current Forward EV/EBITDA of -0.22 falls within the Undervalued range.
-0.14
EV/EBIT
Enveric Biosciences Inc. (ENVB) has a current EV/EBIT of -0.14. The 5-year average EV/EBIT is -1.50. The thresholds are as follows: Strongly Undervalued below -13.54, Undervalued between -13.54 and -7.52, Fairly Valued between 4.53 and -7.52, Overvalued between 4.53 and 10.55, and Strongly Overvalued above 10.55. The current Forward EV/EBIT of -0.14 falls within the Historic Trend Line -Fairly Valued range.
0.00
PS
Enveric Biosciences Inc. (ENVB) has a current PS of 0.00. The 5-year average PS is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward PS of 0.00 falls within the Strongly Undervalued range.
-1.46
P/OCF
Enveric Biosciences Inc. (ENVB) has a current P/OCF of -1.46. The 5-year average P/OCF is -2.92. The thresholds are as follows: Strongly Undervalued below -22.43, Undervalued between -22.43 and -12.67, Fairly Valued between 6.84 and -12.67, Overvalued between 6.84 and 16.60, and Strongly Overvalued above 16.60. The current Forward P/OCF of -1.46 falls within the Historic Trend Line -Fairly Valued range.
-1.32
P/FCF
Enveric Biosciences Inc. (ENVB) has a current P/FCF of -1.32. The 5-year average P/FCF is -3.16. The thresholds are as follows: Strongly Undervalued below -22.32, Undervalued between -22.32 and -12.74, Fairly Valued between 6.42 and -12.74, Overvalued between 6.42 and 16.00, and Strongly Overvalued above 16.00. The current Forward P/FCF of -1.32 falls within the Historic Trend Line -Fairly Valued range.
Enveric Biosciences Inc (ENVB) has a current Price-to-Book (P/B) ratio of 1.75. Compared to its 3-year average P/B ratio of 0.83 , the current P/B ratio is approximately 109.60% higher. Relative to its 5-year average P/B ratio of 11.41, the current P/B ratio is about -84.71% higher. Enveric Biosciences Inc (ENVB) has a Forward Free Cash Flow (FCF) yield of approximately -138.52%. Compared to its 3-year average FCF yield of -302.35%, the current FCF yield is approximately -54.19% lower. Relative to its 5-year average FCF yield of -212.24% , the current FCF yield is about -34.73% lower.
1.57
P/B
Median3y
0.83
Median5y
11.41
-159.41
FCF Yield
Median3y
-302.35
Median5y
-212.24
Financial AI Agent

Competitors Valuation Multiple

The average P/S ratio for ENVB's competitors is 0.09, providing a benchmark for relative valuation. Enveric Biosciences Inc Corp (ENVB) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
AI Stock Picker

Performance Decomposition

1Y
3Y
5Y
Market capitalization of ENVB increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of ENVB in the past 1 year is driven by Unknown.

FAQ

arrow icon

Is Enveric Biosciences Inc (ENVB) currently overvalued or undervalued?

Enveric Biosciences Inc (ENVB) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -1.48. The fair price of Enveric Biosciences Inc (ENVB) is between to according to relative valuation methord.
arrow icon

What is Enveric Biosciences Inc (ENVB) fair value?

arrow icon

How does ENVB's valuation metrics compare to the industry average?

arrow icon

What is the current P/B ratio for Enveric Biosciences Inc (ENVB) as of Aug 30 2025?

arrow icon

What is the current FCF Yield for Enveric Biosciences Inc (ENVB) as of Aug 30 2025?

arrow icon

What is the current Forward P/E ratio for Enveric Biosciences Inc (ENVB) as of Aug 30 2025?

arrow icon

What is the current Forward P/S ratio for Enveric Biosciences Inc (ENVB) as of Aug 30 2025?